MolNFT v1 · #120001 · protein

AlphaFold monomer V2.0 prediction for ERO1-like protein alpha (B6CVD7)

B6CVD7: “AlphaFold monomer V2.0 prediction for ERO1-like protein alpha (B6CVD7)”. 6 pockets (best druggability 0.72). MolNFT v1 #120001 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession: B6CVD7
Type: protein
Length: 468 residues
Chains: 1
Collection: MolNFT v1 / AlphaFold
Contract: 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner: 0xaa53776A41fB2e67da75A96E8a53746b6874aAB4
Molecule: ERO1-like protein alpha
UniProt: B6CVD7
Pockets: 6 · best druggability 0.72

Structure

1 distinct chain · 51% helix, 5% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	ERO1-like protein alpha	protein	468	51% helix, 5% strand	B6CVD7

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	458	0.72	0.82	60	empty
2	368	0.58	0.75	49	empty
3	77	0.49	0.83	13	empty
4	117	0.39	0.75	17	empty
5	67	0.39	0.79	18	empty

Modifications

Observed in the structure: 2 disulfide (disulfide).

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt B6CVD7
Elsewhere: UniProt B6CVD7 · AlphaFold DB B6CVD7

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.